You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The Washington Post reports Xavier Becerra has been confirmed as US Department of Health and Human Services secretary.
With $1.2 billion in funding earmarked for more than 40 projects, the portfolio represents a path out of the SARS-CoV-2 pandemic for the US.
The administration will expand COVID-19 testing for schools and underserved populations, increase manufacturing of testing supplies, and increase genomic sequencing.
The collaborators are requesting submissions including budget proposals to scale all supporting components of diagnostic test manufacturing.
The test uses isothermal nucleic acid amplification to return results in 20 minutes at the point of care, and demonstrated 98 percent agreement with PCR testing.
The test, a version of the company's rapid SARS-CoV-2 assay, will be designed for both point-of-care and at-home use as an over-the-counter product.
President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.
The Wall Street Journal reports on an increased push for COVID-19 testing in the US.
Xavier Becerra, the Health and Human Services Secretary nominee says his main focus, if confirmed, would be the pandemic, the Wall Street Journal reports.
According to the New York Times, President-elect Joe Biden is nominating Xavier Becerra to lead the Department of Health and Human Services.
Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.
NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.
Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.
In Science this week: review discusses advances in liquid biopsies, and more.